Viz.ai Gets FDA Approval for Early Warning System for Stroke Care

Viz.ai Gets FDA Approval for Early Warning System for Stroke Care

According to the CDC, stroke is the fifth leading cause of death in the US, killing about 140,000 people each year. More than 795,000 people in the US have a stroke each year, adding up to an estimated $34 billion in health care services, medicines to treat stroke and missed days of work. Detecting signs of a potential stroke early can be critically important to preventing long term disability or death. Patients who arrive at the emergency room within three hours of their first symptoms often have less disability than those who received delayed care.

FDA Establishes Precedent by Approving AI-Powered Stroke Triage Software

FDA Establishes Precedent by Approving AI-Powered Stroke Triage Software

The software is a clinical decision support tool that uses artificial intelligence (AI) to analyze CT imaging for indications of stroke. If a suspected large vessel blockage is identified, the algorithm will automatically send a text notification to a neurovascular specialist.

FDA clears Viz.ai's stroke detection software

FDA clears Viz.ai's stroke detection software

February 13, 2018 -- In a move that blazes a regulatory trail for developers of imaging artificial intelligence (AI) software, the U.S. Food and Drug Administration (FDA) has given its blessing to Viz.ai for Contact, an AI-based application that analyzes CT images and notifies providers that a patient might be having a stroke